Overview

Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

Status:
Unknown status

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

This study is being carried out to find out whether there is reduction in vancomycin-induced kidney injury (nephrotoxicity) when vancomycin is given as intermittent versus continuous infusion. This study will recruit 220 subjects from 2 hospitals over a period of 3 years. Participants are invited if they have an infection that requires prolonged vancomycin therapy (> more than 10 days).

Phase:

N/A

Details

Lead Sponsor:

National University Hospital, Singapore

Collaborator:

Tan Tock Seng Hospital

Treatments:

Vancomycin